UK's Haleon set for worst day since debut after outlook cut, sales miss

By Reuters News

** Haleon HLN.L shares tumble as much as 17% to 310.5p by 1051 GMT

** Stock set for worst day since 2022 listing, if losses hold

** HLN worst performer on European and British benchmark indices .STOXX, .FTSE

** Consumer health group cuts 2026 revenue growth forecast to ~2.5%, below analysts' expectation

** Q3 organic revenue misses estimates

** CEO warns staff of "difficult choices" ahead, according to memo seen by Reuters

** Top end of medium-term organic revenue growth target "looks like a stretch" - RBC Capital Markets

** Adds consumer health remains among least-favoured sectors following rival Reckitt's RKT.L results

** HLN down ~13% YTD

https://www.reuters.com/graphics/HALEON-STOCKS/gdvzggmrqpw/chart.png

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk